Stocks Health care GRI
NASDAQ · Health careGRI Bio, Inc. (GRI)
It posted a net loss of $9.7M. In fiscal 2025 capital spending exceeded operating cash flow by $10.2M. At June 30, 2026 it held $10.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
What GRI Bio, Inc. does
GRI Bio, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GRI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$12M | -$121.80 | -$10.2M |
| 2024 | n/a | -$8.2M | -$1,545.55 | -$8.6M |
| 2023 | n/a | -$13M | -$140,476.53 | -$9M |
| 2022 | n/a | -$3.2M | -$124,066.88 | -$1.1M |
| 2021 | $0 | -$9.3M | -$255,326.04 | -$8.3M |
| 2021 | $100K | -$4.8M | -$192,393.57 | -$3.7M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What GRI Bio, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026
- August 14, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- June 18, 2026Other event 8-K
- May 14, 2026
- May 13, 2026Passive stake changed SCHEDULE 13G/A
- May 13, 2026
- February 13, 2026Passive stake changed SCHEDULE 13G/A
- February 10, 2026Passive stake changed SCHEDULE 13G/A
- February 4, 2026
Questions about GRI
What does GRI Bio, Inc. do?
GRI Bio, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GRI.
Is GRI Bio, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $9.7M.
When did GRI Bio, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 8, 2026.
Similar companies
Compare GRI with
Follow GRI
Get an email when GRI Bio, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow GRI: get an email when it filesWhere the numbers come from
Financial figures are the values GRI Bio, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.